Nubeqa 300 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FP9DP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,016
Award facts
- Contract value 100% obligated
- $23,016.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,016.00 to AmerisourceBergen Drug Corp for the supply of Nubeqa (300 mg tablets, 120-count package) on February 4, 2026, with an ultimate completion date of February 26, 2026. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's parent company, Cencora, Inc., which maintains a comprehensive Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries to military healthcare systems globally.
Nubeqa (darolutamide) is a prescription medication used in the treatment of prostate cancer, reflecting DLA's ongoing support of pharmaceutical supply needs for military personnel and veteran healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability in fulfilling federal medical procurement requirements across multiple therapeutic domains through its extensive contract portfolio with defense and civilian health agencies. The delivery order represents a routine task order execution under the larger IDC framework, enabling efficient and streamlined procurement of critical pharmaceutical commodities for Department of Defense medical facilities and treatment centers.
Quick answers
Who was awarded contract SPE2DR26FP9DP?
SPE2DR26FP9DP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FP9DP worth?
The government has obligated $23,016 on SPE2DR26FP9DP.
Is contract SPE2DR26FP9DP an order under another contract?
Yes. SPE2DR26FP9DP is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP9DP competed?
The extent of competition for SPE2DR26FP9DP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award